rs5791053
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_004171.4(SLC1A2):c.17+47839_17+47840insA variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004171.4 intron
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 41Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004171.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC1A2 | TSL:1 MANE Select | c.17+47839_17+47840insA | intron | N/A | ENSP00000278379.3 | P43004-1 | |||
| SLC1A2 | TSL:1 | c.5+48825_5+48826insA | intron | N/A | ENSP00000379099.2 | A0A2U3TZS7 | |||
| SLC1A2 | c.-536-47802_-536-47801insA | intron | N/A | ENSP00000494258.1 | A0A2R8YD46 |
Frequencies
GnomAD3 genomes AF: 0.448 AC: 67917AN: 151710Hom.: 16406 Cov.: 0 show subpopulations
GnomAD4 exome AF: 0.495 AC: 409988AN: 828334Hom.: 102830 Cov.: 2 AF XY: 0.496 AC XY: 189632AN XY: 382652 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.448 AC: 67954AN: 151828Hom.: 16417 Cov.: 0 AF XY: 0.456 AC XY: 33872AN XY: 74222 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.